20 September 2019
Key Family 2 Patent Granted in Japan for RECCE® Antibiotics

19 September 2019
HOOKIPA to Present Data Demonstrating the Potential of its TheraT® Technology at the Upcoming CICON Conference in Paris

19 September 2019
Clinigen Full year results -Transformational year - platform taking shape to support higher organic growth

17 September 2019
Polyganics Achieves Positive 3-month Follow-up Data of ENCASE I, the First Clinical Trial for LIQOSEAL®

12 September 2019
Crescendo Biologics to collaborate with world-leading oncology groups at the University of Oxford and the University of Surrey

11 September 2019
Xellia Pharmaceuticals appoints Peter Baker as Chief Commercial Officer, Xellia North America

09 September 2019
Lightcast Discovery Set to Deliver Step-change in Complex Cell Analysis, Raises £1.3m in Seed Financing to Expand Pilot Studies

05 September 2019
Crescendo Biologics strengthens leadership team with appointment of ex-GSK Stewart Kay, as Chief Business Officer

04 September 2019
Bleepa™ – the revolutionary clinical messaging app – showcased at NHS Expo 2019

04 September 2019
NorthSea Therapeutics strengthens its management team with the appointment of Mats Blom as CFO

03 September 2019
Velabs Therapeutics announces strategic partnership with alytas therapeutics to develop a novel immune-based therapy for obesity

03 September 2019
Next-Gen Molecular Assay Play, Biofidelity Secures Seed Financing and Appoints Dr Heiner Dreismann as Senior Advisor

03 September 2019
Forbion Participates in £100m Series B Financing of Achilles Therapeutics

30 August 2019
AU$5m Federal Government Grant for University and Industry Collaboration with Recce Pharmaceuticals

29 August 2019
HOOKIPA Pharma to Present at Upcoming Investor Conferences in September

29 August 2019
FDA Positive Response for Recce Scaled Manufacture and Quality

28 August 2019
Immatics and Celgene Enter Strategic Collaboration to Develop Novel Adoptive Cell Therapies

21 August 2019
Atelerix Consortium Awarded £267,000 Innovate UK Grant for Collaboration with the Cell and Gene Therapy Catapult and Rexgenero on Cell Therapy Stabilisation Technologies

13 August 2019
HOOKIPA Pharma Reports Second Quarter 2019 Financial Results and Clinical Progress Highlights

12 August 2019
Proposed placing and subscription to raise £2 million, proposed grant of options, proposed amendment to Share Option Scheme and notice of General Meeting

08 August 2019
Key Family 2 Patent Granted in Europe for RECCE® Antibiotics

01 August 2019
Recce to Give Opening R&D Address at 2019 World Antibiotic Resistance Congress

01 August 2019
Cristal Therapeutics appoints Dr Werner Cautreels as a new Director and Board Chairman and Andre Verwei as Chief Financial Officer

31 July 2019
GHO Capital announces the sale of Caprion Biosciences

26 July 2019
BleepaTM – revolutionising clinical messaging

23 July 2019
Crescendo Biologics’ second oncology-targeted Humabody® licensed by Takeda

17 July 2019
Karus Therapeutics Strengthens Clinical Leadership Team with Appointment of Dr Hilary McElwaine-Johnn, MD as Chief Medical Officer

16 July 2019
Forbion Portfolio Company, AM-Pharma Raises €116m to Conduct Pivotal Phase III Trial of recAP in Acute Kidney Injury

16 July 2019
Clinigen: Year end trading update

16 July 2019
AM-Pharma Raises €116m [$133m] to Conduct Pivotal Phase III Trial of recAP in Acute Kidney Injury

16 July 2019
Abcam Enters Cell Editing Market Through Acquisition of EdiGene’s Knock-out Cell Lines and Lysates Portfolio

15 July 2019
Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform

15 July 2019
Imugene Enhances Portfolio with Compelling Oncolytic Virus from City of Hope, a Cancer Centre in Los Angeles, California

12 July 2019
HOOKIPA Announces FDA Clearance of IND Application for HB-201 Clinical Trial to Treat HPV-Positive Cancers

11 July 2019
Prescient Therapeutics Initiates Phase 1b Clinical Trial for First-in Class Anti-Cancer Drug PTX-100 in Patients with Multiple Cancers

11 July 2019
Dr Neil Thompson Appointed Chief Scientific Officer of Healx to Spearhead Drug Discovery Expansion

10 July 2019
Outcome of strategic review and trading update

09 July 2019
Recce Board Changes - Appointment of Independent Chair and Additional Director

08 July 2019
Imugene: New HER-Vaxx Cancer Vaccine trial data presented at the European Society of Medical Oncology World Congress on Gastrointestinal Cancer

08 July 2019
Immatics Appoints Harpreet Singh as Chief Executive Officer

05 July 2019
Seventure Partners Announces First Close of New Fund, Sport & Performance Capital

04 July 2019
Business Update and Board Changes

03 July 2019
Confo Therapeutics and DyNAbind announce drug discovery collaboration to identify novel GPCR-modulating compounds

01 July 2019
Seventure Partners Life Sciences Corporate Update Health for Life: March 2019 – June 2019

01 July 2019
RevoluGen announces a global distribution agreement for its combined High Molecular Weight DNA (HMW-DNA) extraction and size selection product Fire Monkey / Fire Flower with Merck

27 June 2019
Emergex Signs an R&D Agreement with IMCB to Develop a Vaccine for the Emerging Threat of Hand, Foot & Mouth Disease

26 June 2019
RevoluGen Appoints Stefano Giolito as Chief Marketing Officer

26 June 2019
Clinigen - MHRA licenses two Melatonin products indicated for short-term jet-lag treatment in adults

24 June 2019
Clinigen broadens partnership with Accord Healthcare to supply and distribute Cardioxane® and Savene® in Poland

20 June 2019
Confo Therapeutics receives €1.7 million grant from VLAIO to progress novel GPCR-modulating compounds for an orphan indication

20 June 2019
Microbiotica Presenting at Key Industry Events during Summer 2019

07 June 2019
British Company Behind Groundbreaking Breast Cancer Treatment

06 June 2019
Astex Pharmaceuticals and Otsuka announce results of the phase 3 ASCERTAIN study of the novel oral cedazuridine and decitabine fixed-dose combination (ASTX727) in patients with myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML)

04 June 2019
Updated Phase Ib HER-Vaxx data presented at the American Society of Clinical Oncology 2019 Annual Meeting

04 June 2019
National Care Group expands into Wales for the first time with the acquisition of the Integra Group

03 June 2019
Leading Physician to Chair Clinical Advisory Committee

30 May 2019
Autifony Therapeutics achieves second milestone in agreement with Boehringer Ingelheim for a novel therapeutic approach to a range of CNS disorders

29 May 2019
First Czech Republic Diabetic Patient with Critical Limb Ischaemia Treated with Novel Regenerative Therapy by Associate Professor Václav Procházka at University Hospital Ostrava

28 May 2019
ADC Therapeutics Expands to Third Program Using Synaffix’s ADC Platform under Existing Agreement

28 May 2019
Rexgenero Successfully Expands Manufacturing of REX-001 through Partnership with German Red Cross Blood Donor Service

22 May 2019
Morphoseq™ Novel DNA Sequencing Technology Enables Highly Accurate and Cost Effective Long Read Sequencing on Short Read NGS Platforms

21 May 2019
HOOKIPA Pharma Reports First Quarter 2019 Financial Results and Recent Business Highlights

20 May 2019
Global Biotechnology and Venture Capital Executive Joins Imugene Board

17 May 2019
Cristal Therapeutics to present data at the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting on lead clinical candidate CPC634 in patients with solid tumors

16 May 2019
Longas Launches, Unveiling Morphoseq™ Long Read DNA Sequencing Technology

15 May 2019
Civica Rx and Xellia Pharmaceuticals join forces to reduce chronic drug shortages

13 May 2019
New tissue clearing kits and reagents for faster, accurate 3D imaging

08 May 2019
HOOKIPA Achieves Research Milestone in HBV Collaboration and License Agreement with Gilead

07 May 2019
Urovant Sciences Presents Positive Pivotal Data for Vibegron During Plenary Session at American Urological Association Annual Meeting

07 May 2019
Confo Therapeutics raises €30 million in Series A financing

07 May 2019
Engitix Ltd Appoints Gino Van Heeke as Chief Scientific Officer

07 May 2019
WISE enrols first patient in pivotal clinical study of novel neuro-electrodes for brain monitoring

02 May 2019
AMAL Therapeutics enters clinical collaboration with Boehringer Ingelheim to evaluate ATP128 in combination with BI754091

01 May 2019
Clinigen appoints James Meyer as General Manager of Commercial Medicines in the US

01 May 2019
Cell Medica collaborators, Baylor College of Medicine and Texas Children’s Hospital, present preclinical data for an off-the-shelf CAR-NKT therapy platform at American Society of Gene & Cell Therapy 22nd Annual Meeting

01 May 2019
Dr. James Summers Appointed to Mission Therapeutics’ Board of Directors

30 April 2019
Cell Medica collaborators, Baylor College of Medicine and Texas Children’s Hospital, present positive early patient data from CAR-NKT neuroblastoma trial at American Society of Gene & Cell Therapy 22nd Annual Meeting

30 April 2019
Biotec Pharmacon Q1 2019 Results

30 April 2019
Congenica Raises Additional £13.25M ($17.1M) to Reach Total of £23.3M ($30.1M) for Series B Funding Round

30 April 2019
ALENTIS Therapeutics launches, raising CHF 12.5m in a Series A to develop novel therapeutics in advanced liver disease and cancer

29 April 2019
National Care Group appoints James Allen as Chief Executive Officer

25 April 2019
HOOKIPA Appoints David R. Kaufman to its Board of Directors

24 April 2019
Rexgenero Presents Update on Phase III Clinical Trials with REX-001, a Cell-based Therapy for Critical Limb Ischaemia

18 April 2019
Congenica Co-founder and Scientific Director Dr Matthew Hurles Elected to Fellowship of the Royal Society

18 April 2019
HOOKIPA Pharma Announces Pricing of Initial Public Offering

18 April 2019
SkinBioTherapeutics plc: Director Appointment

17 April 2019
Cell Medica collaborator, Baylor College of Medicine, showcasing promise of CAR-NKT therapies at American Society of Gene & Cell Therapy 22nd Annual Meeting

12 April 2019
Astex Pharmaceuticals Celebrates as Second New Cancer Drug Receives US Marketing Approval

11 April 2019
Autifony reports positive results in Phase Ib trial with AUT00206, its novel Kv3 ion channel modulator

10 April 2019
Synaffix Announces License Agreement worth up to $125 million with Leading Chinese ADC Developer, Shanghai Miracogen

10 April 2019
Polyganics Builds New Facility to Continue Growth, Supported by RIG Subsidy of €3.8 Million

09 April 2019
Rexgenero To Present at Upcoming Investor and Cell & Gene Therapy Conferences

09 April 2019
Immatics Initiates Third Phase I Clinical Trial of its Unique ACTengine® Platform in Patients with Advanced Solid Cancers

09 April 2019
CEO of Feedback Medical appointed CEO of Feedback plc

08 April 2019
SkinBiotix® shows efficacy in first human study

04 April 2019
Theodora Harold to be appointed new CEO at Crescendo Biologics

03 April 2019
Medical University Vienna presents positive new data on one of Imugene’s lead PD-1 mimotope cancer vaccines at the American Association for Cancer Research 2019 Annual Meeting

03 April 2019
AgomAb Therapeutics Completes Euros 21m Series A Financing

02 April 2019
EspeRare enters into partnership with Dermelix Biotherapeutics to develop DMX-101, an in utero treatment for X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)

02 April 2019
Biotec Pharmacon’s subsidiary, ArcticZymes, granted €254k funding from Eurostars for a synthetic biology project

02 April 2019
Clinigen completes acquisition of US rights to Proleukin

02 April 2019
New Data on Imugene’s Lead PD-1 KEY-Vaxx and HER-2 B-Vaxx Cancer Vaccines presented at the American Association for Cancer Research 2019 Annual Meeting

02 April 2019
Positive New Data on Imugene’s HER-Vaxx Cancer Vaccine Phase Ib trial presented at the American Association for Cancer Research 2019 Annual Meeting

01 April 2019
NanoString and Abcam Enter Commercial Partnership to Provide Expanded Menu of Antibodies for GeoMx Digital Spatial Profiler

01 April 2019
Congenica Announces On-Premise Deployment Option for its SapientiaTM Platform

29 March 2019
SkinBioTherapeutics plc: CEO Designate Appointment

26 March 2019
Clinigen’s Foscavir® gains approval for HHV-6 encephalitis in Japan

25 March 2019
Abcam collaborates with Visikol to develop new tools for improved tissue clearing and 3D imaging

25 March 2019
F-star Presents New Data on its Tetravalent Bispecific Antibodies at the AACR 2019 Annual Meeting

25 March 2019
Downing FOUR VCT Healthcare Share Class open for tax year-end investments

25 March 2019
UK BIOTECH BOOM: 65% growth in UK biotechnology research and development companies since 2016 as sector attracts record investment

21 March 2019
National Care Group expands in Gloucester by completing acquisition of Branksome House Care Services

20 March 2019
Imugene’s Pre-IND FDA Meeting Provides Guidance for KEY-Vaxx Immunotherapy Clinical Development Plan

18 March 2019
ART MEDICAL: New Technologies Needed to Address Inadequate Implementation of Nutritional Guidelines Across the Majority of Intensive Care Units

18 March 2019
China National Biotec Group (CNBG) and ImmunoBiology Ltd enter licensing agreement to co-develop next generation vaccine against pneumococcal disease in Greater China

14 March 2019
USA Patent Granted for Recce's Antibiotics

14 March 2019
Imugene Announces First Patient Dosed in the Open-Label Phase 2 Study with HER-Vaxx Cancer Vaccine for Advanced Gastric Cancer

05 March 2019
Health for Life Capital II™, World Leading Microbiome-focused Fund Announces its First Close

04 March 2019
Clinigen and Eiger BioPharmaceuticals launch worldwide Managed Access Program for lonafarnib for patients with Progeria and Progeroid Laminopathies

01 March 2019
Xellia Pharmaceuticals Divests Raleigh, North Carolina Production Facilities to Sagent Pharmaceuticals

01 March 2019
Seventure Partners Life Sciences Corporate Update September 2018 – February 2019

28 February 2019
Confo Therapeutics forms Scientific Advisory Board as it accelerates development of proprietary drug discovery engine

27 February 2019
Clinigen half year results - Good H1 performance with adjusted EPS up 9% and strong cash flow

27 February 2019
Dr. Athanasios Papadopoulos joins Emergex as Chief Medical Officer

27 February 2019
Abcam moves to new purpose-built global headquarters

26 February 2019
Cell Medica Awarded USD 8.7 Million CPRIT Grant to Accelerate CMD-502 Off-the-shelf CAR-NKT Cell Therapy into Clinical Development

26 February 2019
Immatics Announces Clinical Trial Collaboration in Immunotherapy for Solid Cancers

26 February 2019
HOOKIPA Pharma Raises $37.4 million (€33.2 million) in Series D Financing

22 February 2019
Clinigen granted additional indication for Glycopyrronium Bromide to treat paediatric and adolescent severe hypersalivation

20 February 2019
Seventure Keeps up Pace of Its International Microbiome Investments, Closing Four Deals Spanning Seed to Series C

19 February 2019
Xellia Pharmaceuticals Receives US FDA Approval for Premixed Vancomycin Injection

18 February 2019
SkinBioTherapeutics plc - Issue of Equity and Related Party Transaction

18 February 2019
Recce Successfully Raises AUD$1.8 million to Advance Lead Antibiotic Program

18 February 2019
Emergex Secures State-of-the-art R&D Facility and Hires a Chief Scientific Officer to Drive Development of its Vaccines

15 February 2019
HOOKIPA Appoints Michael A. Kelly as Independent Director

14 February 2019
Feedback Medical appoints radiologist and NHS England Clinical Entrepreneur Fellow as CEO

14 February 2019
SkinBioTherapeutics Half Year Results

12 February 2019
SAW Diagnostics Receives £1.5M Innovate UK Funding to Support Commercialisation of its Point-of-Care Diagnostics Technology Platform

07 February 2019
Biotec Pharmacon’s subsidiary, ArcticZymes launches its first ligase enzyme

05 February 2019
Nick Keher appointed CFO of Clinigen Group

04 February 2019
Biotec Pharmacon awarded grant from Research Council of Norway to develop next-generation wound product

31 January 2019
Interim update on human studies and extension of IP portfolio

30 January 2019
Biotec Pharmacon Q4 2018 Results

29 January 2019
Biotec Pharmacon finalises Post Market study on Woulgan®

28 January 2019
Abcam expands custom services capabilities with the acquisition of Calico Biolabs

28 January 2019
Microbiotica Presenting at Key Microbiome Events in Q1 2019

24 January 2019
Feedback plc Half Year Result

24 January 2019
New Combined Diagnostic and Antimicrobial Susceptibility Test Enables Resistance-Guided Therapy for Gonorrhoea

22 January 2019
Abcam and the Loulou Foundation partner to develop key research tools for CDKL5 deficiency disorder

18 January 2019
Autifony Therapeutics achieves first milestone in agreement with Boehringer Ingelheim for a novel therapeutic approach to a range of CNS disorders

15 January 2019
Clinigen Half Year trading update

10 January 2019
Clinigen extends exclusive European clinical trial sourcing and supply agreement with Accord Healthcare

03 January 2019
Crescendo Biologics announces Humabody® evaluation in CAR-T by Takeda

03 January 2019
US Patent Office Grants the 100th Patent to Immatics Underpinning the Company’s Leading Role in the Field of Innovative Immunotherapies

03 January 2019
Confo Therapeutics Announces Exclusive, Worldwide License Agreement with VIB for Powerful Novel Structure Determination Technology

02 January 2019
HOOKIPA Achieves First Research Milestone in HIV Collaboration and License Agreement with Gilead